HH Biotechnology Holdings Company (HHBT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate HH Biotechnology Holdings Company's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
18.06
Strong
WeakModerateStrong
P/B Ratio
1.56
Strong
WeakModerateStrong
Earnings Yield
5.64%
Strong
WeakModerateStrong
Profitability Health
2015Return on Equity
8.78%
Weak
WeakModerateStrong
Operating Margin
38.78%
Strong
WeakModerateStrong
Net Profit Margin
30.99%
Strong
WeakModerateStrong
Growth Indicators
2015Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data
Efficiency & Liquidity
2015Current Ratio
2.32
Strong
WeakModerateStrong
Quick Ratio
2.32
Strong
WeakModerateStrong
Asset Turnover
0.17x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
8.04%
Strong
WeakModerateStrong
EV / Free Cash Flow
10.97x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.95x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.857
Moderate
WeakModerateStrong
Return on Invested Capital
-112.64%
Weak
WeakModerateStrong
Cash Conversion Cycle
-245.98 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HHBT.
View Financial Statements